Search

everythinglearnresearchcommunity

for

Search:↓

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

Older women taking spironolactone for hair loss may need yearly potassium checks due to a higher risk of hyperkalemia.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

Spironolactone effectively treats female pattern hair loss but requires ongoing use to maintain results.

Platelet-rich plasma (PRP) shows no significant benefit for bone and soft-tissue injuries or wound healing, and its effectiveness may improve with customization.

Krill oil may help reduce prostate enlargement and growth.

Taking spironolactone doesn't increase the chance of breast cancer coming back.

The treatment is safe and shows promise for metastatic breast cancer.

Leuprolide may better manage cholesterol and blood pressure in PCOS than spironolactone.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Combining low-dose oral minoxidil and spironolactone may improve hair growth safely.

The treatment combination is effective and generally safe for lung cancer.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Monitoring for adverse effects in clinical treatments is crucial.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

A reliable method was developed to measure aristolochic acid-I in rat blood.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.